Made available in DSpace on 2022-04-29T08:46:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2022-03-01; Peroxisome proliferator-activated receptors are promising therapeutic targets for metabolic diseases, including obesity, diabetes, and dyslipidemia. This study describes the design, synthesis and pharmacological evaluation of stilbene-based compounds as dual PPARα/γ partial agonists with potency in the ...